HKSE - Delayed Quote HKD

HUTCHMED (0013.HK)

Compare
21.250
-2.300
(-9.77%)
At close: 4:08:28 PM GMT+8
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
837,999.000
837,999.000
426,409.000
356,128.000
227,976.000
Cost of Revenue
384,447.000
384,447.000
311,103.000
258,234.000
188,519.000
Gross Profit
453,552.000
453,552.000
115,306.000
97,894.000
39,457.000
Operating Expense
435,177.000
435,177.000
522,999.000
426,211.000
236,125.000
Operating Income
18,375.000
18,375.000
-407,693.000
-328,317.000
-196,668.000
Net Non Operating Interest Income Expense
35,386.000
35,386.000
8,947.000
1,484.000
2,449.000
Pretax Income
58,308.000
58,308.000
-410,422.000
-215,740.000
-189,734.000
Tax Provision
4,509.000
4,509.000
-283.000
11,918.000
4,829.000
Net Income Common Stockholders
100,780.000
100,780.000
-360,835.000
-194,648.000
-125,730.000
Diluted NI Available to Com Stockholders
100,780.000
100,780.000
-360,835.000
-194,648.000
-125,730.000
Basic EPS
0.12
0.12
-0.43
-0.25
-0.18
Diluted EPS
0.12
0.12
-0.43
-0.25
-0.18
Basic Average Shares
849,654.296
849,654.296
847,143.540
792,684.524
697,931.437
Diluted Average Shares
869,196.348
869,196.348
847,143.540
792,684.524
697,931.437
Total Expenses
819,624.000
819,624.000
834,102.000
684,445.000
424,644.000
Net Income from Continuing & Discontinued Operation
100,780.000
100,780.000
-360,835.000
-194,648.000
-125,730.000
Normalized Income
100,780.000
100,780.000
-360,835.000
-295,941.850
-125,730.000
Interest Income
36,145.000
36,145.000
9,599.000
2,076.000
3,236.000
Interest Expense
759.000
759.000
652.000
592.000
787.000
Net Interest Income
35,386.000
35,386.000
8,947.000
1,484.000
2,449.000
EBIT
59,067.000
59,067.000
-409,770.000
-215,148.000
-188,947.000
EBITDA
67,274.000
67,274.000
-401,106.000
-207,958.000
-182,886.000
Reconciled Cost of Revenue
384,447.000
384,447.000
311,103.000
258,234.000
188,519.000
Reconciled Depreciation
8,207.000
8,207.000
8,664.000
7,190.000
6,061.000
Net Income from Continuing Operation Net Minority Interest
100,780.000
100,780.000
-360,835.000
-194,648.000
-125,730.000
Total Unusual Items Excluding Goodwill
--
--
--
121,310.000
--
Total Unusual Items
--
--
--
121,310.000
--
Normalized EBITDA
67,274.000
67,274.000
-401,106.000
-329,268.000
-182,886.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
--
--
--
20,016.150
--
12/31/2020 - 6/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

068760.KQ Celltrion Pharm, Inc.
55,200.00
-1.25%
 
0ET.MU Esperion Therapeutics Inc
2.2450
-0.44%
 
MB8.F Moberg Pharma AB (publ)
0.7555
-1.44%
 
SPBBF Speakeasy Cannabis Club Ltd.
0.0000
0.00%
 
R9U2.F Green Thumb Industries Inc.
6.66
-1.84%
 
MEGA.BK Mega Lifesciences Public Company Limited
33.75
+1.50%
 
EVT.VI Evotec SE
8.01
+1.84%
 
CEL.L Celadon Pharmaceuticals Plc
16.00
0.00%
 
RAPH Raphael Pharmaceutical Inc.
1.0000
0.00%
 
MKGAF Merck KGaA
147.55
+1.46%